PROCESS FOR THE PREPARATION OF TETRAZINE DERIVATIVES

The present invention provides a process for the preparation of a tetrazine derivative of formula (I), or a pharmaceutically acceptable salt thereof wherein R1 represents a hydrogen atom, a straight or branched C1-C6 alkyl group, C2-C6 alkenyl group or C2-C6 alkynyl group, which C1-C6 alkyl group, C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHATURVEDI, ROHIT, BAVISKAR, PRAVIN, GUPTE, RAJAN
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a process for the preparation of a tetrazine derivative of formula (I), or a pharmaceutically acceptable salt thereof wherein R1 represents a hydrogen atom, a straight or branched C1-C6 alkyl group, C2-C6 alkenyl group or C2-C6 alkynyl group, which C1-C6 alkyl group, C2-C6 alkenyl group and C2-C6 alkynyl group is unsubstituted or substituted with 1, 2 or 3 substituents selected from halogen atoms, straight or branched C1-C4 alkoxy groups, C1-C4 alkylthio groups, C1-C4 alkylsulphinyl groups, C1-C4 alkylsulphonyl groups and phenyl groups, which phenyl groups are unsubstituted or substituted with one or more substituents selected from C1-C4 alkyl groups, C1-C4 alkoxy groups and nitro groups; or R1 represents a C3-C8 cycloalkyl group; and R2 represents a group of formula -(C=O)NR3R4, wherein R3 and R4 are independently selected from hydrogen atoms, C1-C4 alkyl groups, C2-C4 alkenyl groups and C3-C8 cycloalkyl groups, which process comprises: i) providing a compound of formula (III), wherein R1 is as defined; R1-N=C=O ii) absorbing the compound of formula (III) into a solvent to obtain a solution of the compound of formula (III); iii) adding to the thus obtained solution a compound of formula (II), to obtain a compound of formula (I), as defined above, wherein R2 is as defined above; iv) decomposing any excess compound of formula (III) remaining by addition of water; and v) optionally salifying the thus obtained compound with a pharmaceutically acceptable acid, or base. La présente invention concerne un procédé de préparation d'un dérivé de tétrazine de formule (I), ou d'un sel pharmaceutiquement acceptable de celui-ci, dans lequel R1 représente un atome d'hydrogène, ou un groupe alkyle en C1-C6, alcényle en C2-C6 ou alcynyle en C2-C6 linéaire ou ramifié non substitué ou portant 1, 2 ou 3 substituants choisis parmi les atomes d'halogène, les groupes alcoxy en C1-C4 linéaires ou ramifiés, (alkyl en C1-C4)thio, (alkyl en C1-C4)sulfinyle, (alkyl en C1-C4)sulfonyle et phényle, les groupes phényle étant non substitués ou portant un ou plusieurs substituants choisis parmi les groupes alkyle en C1-C4, alcoxy en C1-C4 et nitro ; ou bien R1 représente un groupe cycloalkyle en C3-C8 ; et R2 représente un groupe de formule -(C=O)NR3R4 dans laquelle R3 et R4 sont indépendamment choisis parmi les atomes d'hydrogène, les groupes alkyle en C1-C4, alcényle en C2-C4 et cycloalkyle en C3-C8. Ce procédé consiste à i) obtenir un composé de formule R1